Dr guyer (50 Ergebnisse)

Paperback. Zustand: Very Good. Connecting readers with great books since 1972! Used books may not include companion materials, and may have some shelf wear or limited writing. We ship orders daily and Customer Service is our top priority.

Paperback. Zustand: Like New. FIRST THUS. First Edition Thus, First Printing. Published by University of California Press, 2004. Octavo. Paperback. Book is like new.

paperback. Zustand: Very Good. Very good condition. Text looks free of notations/underlining. Light wear to the exterior.

Hardcover. Zustand: new. Hardcover. A life-altering revolution has happened right before your eyes. Yet for a generation, it has been largely invisible. Unblinded is the never-before-heard origin story of intravitreal, anti-VEGF therapies for macular degeneration, and other retinal diseases, and the start-up company that changed the future of eyecare. In the 1990s, age-related macular degeneration (AMD) was the leading cause of blindness in the developed world, with no effective treatments. The disease became known for robbing its elderly victims of their central vision and the opportunity to age gracefully, leaving them with the fear of going blind. Today, this is no longer the case for most people. Going against the grain, three young eye doctors challenged the prevailing views of the ophthalmological establishment and formed a start-up drug company, Eyetech, in 2000 to develop the first anti-VEGF therapy, Macugen. David Guyer, MD, a New York academic; Tony Adamis, MD, a medical research scientist in Boston; and Samir Patel, MD, a leading surgeon based in Chicago, joined forces to refocus the pharmaceutical industry's attention from the front of the eye to the back. This team successfully overcame enormous hurdles to create a therapeutic approach from scratch that, as of 2025, represents >$15bn of revenue in one of the highest billed procedures on Medicare. In Unblinded, you'll discover how a trio of doctors stepped out of their comfort zones into a world where groundbreaking biotechnology tussles with multimillion-dollar risk-taking--often amid financial market turmoil. Despite the turbulence of their journey, David, Samir, Tony, and their many contemporaries have never taken their eyes off the ultimate prize--improving sight. Proceeds from the book go to the non-profit, Wise Eyes Foundation, with a mission to reduce the unmet need in large population retinal diseases through research and patient support. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…

Zustand: New.

Hardcover. Zustand: Good. No Jacket. No wear to the binding, but there are areas of damp staining to the front and rear boards. No slope, no twist, no distortion from reading or improper shelving. Pages are tight and clean with no marks. Light foxing here and there with foxing to the leading edge of the text block. No name of previous owner. No odor. No soiling. No sun fading. No dust jacket.…

paperback. Zustand: Fine.

paperback. Zustand: New. Brand new gift quality softcover Please email for photos. Larger books or sets may require additional shipping charges. Books sent via US Postal.

Zustand: New. pp. 304.

First edition in English (hardback). 4to, xxiv. 104 plates. Rebound in green cloth, with the original card wrappers bound in. This copy was formerly in the Guildhall Library, London, with a bookplate to the front pastedown, a shelfmark to the spine and occasional stamps, but the book is nonetheless in good to very good condition overall.…

Leinen. Zustand: Gut. EA. 164 S. Mit herausnehmbarer Karte. Sehr gut erhalten. Sprache: Deutsch Gewicht in Gramm: 800.

Zustand: New. pp. 304.

Hardcover. Zustand: new. Hardcover. A life-altering revolution has happened right before your eyes. Yet for a generation, it has been largely invisible. Unblinded is the never-before-heard origin story of intravitreal, anti-VEGF therapies for macular degeneration, and other retinal diseases, and the start-up company that changed the future of eyecare. In the 1990s, age-related macular degeneration (AMD) was the leading cause of blindness in the developed world, with no effective treatments. The disease became known for robbing its elderly victims of their central vision and the opportunity to age gracefully, leaving them with the fear of going blind. Today, this is no longer the case for most people. Going against the grain, three young eye doctors challenged the prevailing views of the ophthalmological establishment and formed a start-up drug company, Eyetech, in 2000 to develop the first anti-VEGF therapy, Macugen. David Guyer, MD, a New York academic; Tony Adamis, MD, a medical research scientist in Boston; and Samir Patel, MD, a leading surgeon based in Chicago, joined forces to refocus the pharmaceutical industry's attention from the front of the eye to the back. This team successfully overcame enormous hurdles to create a therapeutic approach from scratch that, as of 2025, represents >$15bn of revenue in one of the highest billed procedures on Medicare. In Unblinded, you'll discover how a trio of doctors stepped out of their comfort zones into a world where groundbreaking biotechnology tussles with multimillion-dollar risk-taking--often amid financial market turmoil. Despite the turbulence of their journey, David, Samir, Tony, and their many contemporaries have never taken their eyes off the ultimate prize--improving sight. Proceeds from the book go to the non-profit, Wise Eyes Foundation, with a mission to reduce the unmet need in large population retinal diseases through research and patient support. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.…

Hardcover. Zustand: Sehr gut. 1 auflage. gross oktav hardcover. sehr gutes exemplar. gebundene schwarze goldgepr.-illustr. leinenausgabe, vorderer vorsatz oben links mit namen und unten mit schwarzem aufkleber, 272 seiten mit 160 schwarzweißen kunstdrucktafeln. gestaltung des bilderteils von dr. h. rieben, nach photos von fratelli alinari. …

hardcover. Zustand: Very Good.

Hardcover. Zustand: new. Hardcover. A life-altering revolution has happened right before your eyes. Yet for a generation, it has been largely invisible. Unblinded is the never-before-heard origin story of intravitreal, anti-VEGF therapies for macular degeneration, and other retinal diseases, and the start-up company that changed the future of eyecare. In the 1990s, age-related macular degeneration (AMD) was the leading cause of blindness in the developed world, with no effective treatments. The disease became known for robbing its elderly victims of their central vision and the opportunity to age gracefully, leaving them with the fear of going blind. Today, this is no longer the case for most people. Going against the grain, three young eye doctors challenged the prevailing views of the ophthalmological establishment and formed a start-up drug company, Eyetech, in 2000 to develop the first anti-VEGF therapy, Macugen. David Guyer, MD, a New York academic; Tony Adamis, MD, a medical research scientist in Boston; and Samir Patel, MD, a leading surgeon based in Chicago, joined forces to refocus the pharmaceutical industry's attention from the front of the eye to the back. This team successfully overcame enormous hurdles to create a therapeutic approach from scratch that, as of 2025, represents >$15bn of revenue in one of the highest billed procedures on Medicare. In Unblinded, you'll discover how a trio of doctors stepped out of their comfort zones into a world where groundbreaking biotechnology tussles with multimillion-dollar risk-taking--often amid financial market turmoil. Despite the turbulence of their journey, David, Samir, Tony, and their many contemporaries have never taken their eyes off the ultimate prize--improving sight. Proceeds from the book go to the non-profit, Wise Eyes Foundation, with a mission to reduce the unmet need in large population retinal diseases through research and patient support. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.…

paperback. Zustand: New. In shrink wrap. Looks like an interesting title.

Kunstleder. Zustand: Gut bis sehr gut. 2. Auflage. Kommissionsverlag H. Rohr, Zürich, 1970, Originakunstlederband mit Deckel- und Rückenprägung, 27 S. Text, 136 S.(ges. 163 S.) Verzeichnis der Straßennamen mit Erläuterungen zur Herkunft. 1 mehrfach gefalteter Plan der Stadt Zürich und ein Anhangsheft (6 S. Ergänzungen)in Tasche im hinteren Innendeckel. Gut erhalten.…

Zustand: As New. Unread book in perfect condition.

Zustand: New. 2012. 0th Edition. Hardcover. A guide to the best methods for carrying out standardized quantitative and qualitative surveys of reptiles, while maximizing comparability of data between sites, across habitats and taxa. It discusses each method, provides protocols for its implementation, and suggests ways to analyze the data. Editor(s): McDiarmid, Roy W.; Foster, Mercedes S.; Guyer, Craig; Gibbons, J. Whitfield; Chernoff, Neil. Num Pages: 424 pages, 51 b/w photographs, 68 line illustrations, 38 tables. BIC Classification: PSVW5; RNC. Category: (P) Professional & Vocational. Dimension: 281 x 221 x 27. Weight in Grams: 1624. Standard Methods for Inventory and Monitoring. 424 pages, Illustrations, maps. Editor(s): McDiarmid, Roy W.; Foster, Mercedes S.; Guyer, Craig; Gibbons, J. Whitfield; Chernoff, Neil. A guide to the best methods for carrying out standardized quantitative and qualitative surveys of reptiles, while maximizing comparability of data between sites, across habitats and taxa. It discusses each method, provides protocols for its implementation, and suggests ways to analyze the data. Cateogry: (P) Professional & Vocational. BIC Classification: PSVW5; RNC. Dimension: 281 x 221 x 27. Weight: 1570. . . . . . …

Zustand: New.

Zustand: new.

Zustand: As New. Unread book in perfect condition.

HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

Zustand: New.

Zustand: New. pp. 417.

Hardback. Zustand: New. From tiny, burrowing lizards to rainforest canopy-dwellers and giant crocodiles, reptile populations everywhere are changing. Yet government and conservation groups are often forced to make important decisions about reptile conservation and management based on inadequate or incomplete data. With contributions from nearly seventy specialists, this volume offers a comprehensive guide to the best methods for carrying out standardized quantitative and qualitative surveys of reptiles, while maximizing comparability of data between sites, across habitats and taxa, and over time. The contributors discuss each method, provide detailed protocols for its implementation, and suggest ways to analyze the data, making this volume an essential resource for monitoring and inventorying reptile abundance, population status, and biodiversity. "Reptile Biodiversity" covers topics including: terrestrial, marine, and aquatic reptiles; equipment recommendations and limitations; ethics of monitoring and inventory activities; statistical procedures; designing sampling programs; and, using PDAs in the field.…

Zustand: New. 2012. 0th Edition. Hardcover. A guide to the best methods for carrying out standardized quantitative and qualitative surveys of reptiles, while maximizing comparability of data between sites, across habitats and taxa. It discusses each method, provides protocols for its implementation, and suggests ways to analyze the data. Editor(s): McDiarmid, Roy W.; Foster, Mercedes S.; Guyer, Craig; Gibbons, J. Whitfield; Chernoff, Neil. Num Pages: 424 pages, 51 b/w photographs, 68 line illustrations, 38 tables. BIC Classification: PSVW5; RNC. Category: (P) Professional & Vocational. Dimension: 281 x 221 x 27. Weight in Grams: 1624. Standard Methods for Inventory and Monitoring. 424 pages, Illustrations, maps. Editor(s): McDiarmid, Roy W.; Foster, Mercedes S.; Guyer, Craig; Gibbons, J. Whitfield; Chernoff, Neil. A guide to the best methods for carrying out standardized quantitative and qualitative surveys of reptiles, while maximizing comparability of data between sites, across habitats and taxa. It discusses each method, provides protocols for its implementation, and suggests ways to analyze the data. Cateogry: (P) Professional & Vocational. BIC Classification: PSVW5; RNC. Dimension: 281 x 221 x 27. Weight: 1570. . . . . . Books ship from the US and Ireland. …

Zustand: New. In English.

Hardback. Zustand: New. From tiny, burrowing lizards to rainforest canopy-dwellers and giant crocodiles, reptile populations everywhere are changing. Yet government and conservation groups are often forced to make important decisions about reptile conservation and management based on inadequate or incomplete data. With contributions from nearly seventy specialists, this volume offers a comprehensive guide to the best methods for carrying out standardized quantitative and qualitative surveys of reptiles, while maximizing comparability of data between sites, across habitats and taxa, and over time. The contributors discuss each method, provide detailed protocols for its implementation, and suggest ways to analyze the data, making this volume an essential resource for monitoring and inventorying reptile abundance, population status, and biodiversity. "Reptile Biodiversity" covers topics including: terrestrial, marine, and aquatic reptiles; equipment recommendations and limitations; ethics of monitoring and inventory activities; statistical procedures; designing sampling programs; and, using PDAs in the field.…